Friday 6 November 2026 Export QGEN’s income statement to Excel — free account

QIAGEN N.V.

QGEN Healthcare Diagnostics & Research

QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.

Revenue: +0.28%
EPS: +7.94%
Free cash flow: +30.5%
Total debt: +13.8%

Quarter to June 2026, against a year earlier

50.88 0.05 +0.10%

Follow QGEN

Alert me

Market cap: $10.5B
P/E: 26.1×
Fwd P/E: 26.0×
Dividend yield: 0.69%
F-score: 8/9
Altman Z: 3.94
Beneish M: −2.60
Dividend safety: 66/100

Overview

QIAGEN N.V. (QGEN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, QIAGEN N.V. (QGEN) trades at a P/B ratio of 3.1×. Over the past ten years it has ranged from 1.7× (June 2016) to 4.6× (October 2020); the current reading is higher than 63% of that period. That is below the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/QGEN/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="QIAGEN N.V. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/QGEN/metrics/pb-ratio">QIAGEN N.V. (QGEN) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	2.7×	(9.53%)
FY2024	3.0×	8.48%
FY2023	2.8×	(17.93%)
FY2022	3.4×	(17.43%)
FY2021	4.1×	(5.16%)
FY2020	4.3×	42.78%
FY2019	3.0×	1.99%
FY2018	3.0×	5.27%
FY2017	2.8×	15.24%
FY2016	2.4×	1.09%

Period	P/B ratio	Change
Jun 2026	2.4×	(3.42%)
Mar 2026	2.5×	(8.59%)
Dec 2025	2.7×	2.51%
Sep 2025	2.7×	(15.10%)
42 more quarters	Free account

Against its own ten years

Low 1.7× High 4.6×

Ten-year median 3.0×

Current reading's percentile 59

Company	P/B ratio
GH Guardant Health, Inc. compare	n/m
ICLR ICON PLC compare	1.7×
RVTY Revvity Inc. compare	2.3×
GRAL GRAIL, Inc. compare	2.4×
QGEN QIAGEN N.V.	3.1×
RDNT RadNet, Inc. compare	4.4×
CRL Charles River Laboratories International, Inc. compare	4.6×
BLLN BillionToOne, Inc. compare	9.9×
MEDP Medpace Holdings, Inc. compare	30.3×
Diagnostics & Research industry median	3.4×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

QIAGEN N.V. (QGEN) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on QGEN

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on QGEN

Stockrow Weekly